share_log

Chardan Capital Maintains Buy on Purple Biotech, Maintains $11 Price Target

Moomoo 24/7 ·  Mar 7 13:56

Chardan Capital analyst Daniil Gataulin maintains Purple Biotech (NASDAQ:PPBT) with a Buy and maintains $11 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment